BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2017
View Archived Issues
KIST presents novel drug candidate for Alzheimer's disease, KDS-2010
Read More
KemPharm reports preliminary data from phase I study of KP-415
Read More
First interim analysis of UNITY-NHL trial of TG-1101 and TGR-1202
Read More
PeptiDream, Shionogi and Sekisui to establish joint venture to manufacture special peptides
Read More
CARsgen's anti-Claudin18.2 CAR T-cell therapy begins phase I study
Read More
Cancer Research UK to collaborate with Biotecnol on development of novel immune-oncology drug
Read More
Radicava launched in U.S. for ALS
Read More
Mice bred to discover unknown genetic modifiers of familial Alzheimer's disease
Read More
NCI grant supports SignalRx's preclinical development of epigenetic-kinase inhibitors for cancer
Read More
Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302
Read More
Patient enrollment begins in phase I trial of CD33-CAR-T cell therapy in CD33-positive AML
Read More
FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV
Read More
Takeda forms immuno-oncology research collaboration with Shattuck
Read More
New targets modifying tau pathology progression identified
Read More
Starpharma and Monash awarded funding from SIEF STEM+ Business Fellowship Program
Read More
EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate
Read More
Novo Nordisk reviews key pipeline events of second quarter 2017
Read More
Chiasma reaches agreement with FDA on phase III trial of octreotide for acromegaly
Read More
Lundbeck reviews highlights of second quarter 2017
Read More
FDA accepts Achieve's IND for cytisine for smoking cessation
Read More
Yeda Research & Development patents protein LYRIC/transcription factor p65 interaction inhibitors
Read More
Beijing Marino Biotechnology describes a transgenic lymphocyte construct identifying EGFRvIII
Read More
Sumitomo Dainippon Pharma divulges new semaphorin-3A inhibitors
Read More
Guangzhou Institutes of Biomedicine and Health presents novel RORC antagonists
Read More
Novel orexin OX1 receptor antagonists discovered at C4X Discovery Holdings
Read More
Soin Neuroscience signs development agreement with Cleveland Diabetes Care for TV-1001sr
Read More